. Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's disease. Curr Med Res Opin. 2024 Oct;40(10):1719-1725. Epub 2024 Sep 1 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.